Allogene Therapeutics logo

Allogene Therapeutics jobs and careers

South San Francisco, CA, United States

About Allogene Therapeutics

Allogene Therapeutics is a clinical-stage biotechnology company pioneering the development of allogeneic chimeric antigen receptor T cell (AlloCAR T™) therapies for cancer. The goal of our allogeneic cell therapy platform is simple: take the same biological processes that allow the first generation autologous CAR T therapies to deliver breakthrough clinical benefits but eliminate the need to create a personalized therapy for each patient. Instead, we start with T cells from healthy donors, which is intended to allow for creation of inventory for “off-the-shelf” use in patients faster, more reliably, and at greater scale.

Employees
350
Headquarters
South San Francisco

Leadership

The top of Allogene Therapeutics's org chart, with how many people report into each leader.

DCPhoto of David Chang

David Chang

Board Member, Allogene Therapeutics

130 reports

GPPhoto of Geoffrey Parker

Geoffrey Parker

Executive Vice President And Chief Financial Officer

57 reports

ZD

Zachary J Roberts M.D.

Executive Vice President Of Research & Development And Chief Medical Officer

36 reports

ZRPhoto of Zachary J. Roberts

Zachary J. Roberts

EVP, Research & Development & CMO

14 reports

BBPhoto of Ben Beneski

Ben Beneski

Chief Technical Officer (cto)

11 reports

SLPhoto of Susan Lundeen

Susan Lundeen

Chief People Officer

5 reports

CCPhoto of Christine Cassiano

Christine Cassiano

Evp, Chief Corporate Affairs & Brand Strategy Officer

1 report

Board

SF

Stephen J. Forman

Scientific Advisor

DMPhoto of Debbie Messemer

Debbie Messemer

Board Member

OW

Owen Witte

Scientific Advisor & Board Member

TG

Thomas F. Gajewski

Scientific Advisor

MB

Malcolm K. Brenner

Scientific Advisor

MP

Matthew Porteus

Scientific Advisor